Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 328

1.

Postprandial peaks as a risk factor for cardiovascular disease: epidemiological perspectives.

Bonora E.

Int J Clin Pract Suppl. 2002 Jul;(129):5-11. Review.

PMID:
12166607
2.

Postprandial glucose regulation: new data and new implications.

Leiter LA, Ceriello A, Davidson JA, Hanefeld M, Monnier L, Owens DR, Tajima N, Tuomilehto J; International Prandial Glucose Regulation Study Group.

Clin Ther. 2005;27 Suppl B:S42-56. Review.

PMID:
16519037
3.

Postprandial hyperglycaemia: noxious effects on the vessel wall.

Hanefeld M.

Int J Clin Pract Suppl. 2002 Jul;(129):45-50. Review.

PMID:
12166606
4.

Should postprandial hyperglycaemia in prediabetic and type 2 diabetic patients be treated?

Charpentier G, Riveline JP, Dardari D, Varroud-Vial M.

Drugs. 2006;66(3):273-86. Review.

PMID:
16526817
5.

Efficacy of biphasic insulin aspart in patients with type 2 diabetes.

Halimi S, Raskin P, Liebl A, Kawamori R, Fulcher G, Yan G.

Clin Ther. 2005;27 Suppl B:S57-74. Review.

PMID:
16519038
6.
7.

Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: a move towards a unified glucose tetrad concept.

Monnier L, Colette C, Owens DR.

Diabetes Metab Res Rev. 2009 Jul;25(5):393-402. doi: 10.1002/dmrr.962. Review.

PMID:
19437415
8.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
9.

What does postprandial hyperglycaemia mean?

Heine RJ, Balkau B, Ceriello A, Del Prato S, Horton ES, Taskinen MR.

Diabet Med. 2004 Mar;21(3):208-13. Review.

PMID:
15008828
10.

Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention.

Unwin N, Shaw J, Zimmet P, Alberti KG.

Diabet Med. 2002 Sep;19(9):708-23. Review.

PMID:
12207806
11.

Defining the role of insulin lispro in the management of postprandial hyperglycaemia in patients with type 2 diabetes mellitus.

Giugliano D, Ceriello A, Razzoli E, Esposito K.

Clin Drug Investig. 2008;28(4):199-210. Review.

PMID:
18345710
12.

Postprandial glucose - a potential therapeutic target to reduce cardiovascular mortality.

Peter R, Okoseime OE, Rees A, Owens DR.

Curr Vasc Pharmacol. 2009 Jan;7(1):68-74. Review.

PMID:
19149642
13.

Control of post-prandial hyperglycemia--an essential part of good diabetes treatment and prevention of cardiovascular complications.

Hanefeld M, Temelkova-Kurktschiev T.

Nutr Metab Cardiovasc Dis. 2002 Apr;12(2):98-107. Review.

PMID:
12189909
14.

Prandial glucose regulation in the glucose triad: emerging evidence and insights.

Beisswenger P, Heine RJ, Leiter LA, Moses A, Tuomilehto J.

Endocrine. 2004 Dec;25(3):195-202. Review.

PMID:
15758245
15.

Postprandial dysmetabolism and large-vessel disease.

Segal P.

Diabetes Nutr Metab. 2002 Dec;15(6 Suppl):3-8. Review.

PMID:
12702001
16.

Glucose metabolism and hyperglycemia.

Giugliano D, Ceriello A, Esposito K.

Am J Clin Nutr. 2008 Jan;87(1):217S-222S. Review.

17.
18.

[Diagnostic criteria for diabetes mellitus].

Tominaga M.

Rinsho Byori. 1999 Oct;47(10):901-8. Review. Japanese.

PMID:
10590663
19.

The postprandial state and the risk of atherosclerosis.

Hanefeld M, Temelkova-Kurktschiev T.

Diabet Med. 1997 Aug;14 Suppl 3:S6-11. Review.

PMID:
9272607
20.

Prandial hyperglycemia: is it important to track and treat?

Hanefeld M, Schaper F.

Curr Diab Rep. 2005 Oct;5(5):333-9. Review.

PMID:
16188167

Supplemental Content

Support Center